Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

From the Editors

TOP November 2015 Vol 8 No 4 - From the Editors

In the November issue of The Oncology Pharmacist, we provide a highlight of a recent study that was presented at the 2015 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on Supportive Care in Cancer on the use of docetaxel plus nintedanib in patients with non–small-cell lung cancer (NSCLC). The study authors found that the combination therapy was well-tolerated, and did not increase the frequency of adverse events associated with antiangiogenic treatment. We also had the opportunity to speak with Anders Mellemgaard, MD, from Herlev University Hospital, Denmark, co-author of the study, about the role of nintedanib in extending survival without reducing the quality of life in patients with NSCLC.

In addition to conference news, we provide valuable insight on the symptom management of patients with chemotherapy and radiotherapy-induced nausea and vomiting, practical information for formulary management and procurement of oncology medications (see page 14), and emerging therapies.

As part of our reader poll (see below), we ask you whether oncology specialty pharmacy promotes coordination of care. Please visit our website, www.TheOncologyPharmacist.com, and let us know whether this is what you have observed in your everyday practice. You can also send comments to info@TheOncologyPharmacist.com.

We hope you will enjoy this issue, and look forward to your feedback.

Related Items
From The Editors: May 2022
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2022 Vol 15, No 3 published on May 6, 2022 in From the Editors
From The Editors March 2022
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in From the Editors
From The Editors
TOP - January 2022 Vol 15, No 1 – Online Only published on January 20, 2022 in From the Editors
From The Editors: November 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - November 2021 Vol 14, No 7 published on November 10, 2021 in From the Editors
From The Editors: October 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - October 2021 Vol 14, No 6 | Biosimilars published on November 5, 2021 in From the Editors, Biosimilars
From The Editors September 2021
Patrick J. Medina, PharmD, BCOP
TOP - September 2021 Vol 14, No 5 published on September 7, 2021 in From the Editors
From The Editors July 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - July 2021 Vol 14, No 4 published on July 20, 2021 in From the Editors
From The Editors May 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - May 2021 Vol 14, No 3 published on May 14, 2021 in From the Editors
From The Editors March 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - March 2021 Vol 14, No 2 published on March 11, 2021 in From the Editors
From The Editors January 2021
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - January 2021 Vol 14, No 1 published on February 9, 2021 in From the Editors
Last modified: July 22, 2021